Biodexa Pharmaceuticals PLC (BDRX)
4.40
+0.55
(+14.29%)
USD |
NASDAQ |
Nov 21, 16:00
4.19
-0.21
(-4.77%)
After-Hours: 06:09
Biodexa Pharmaceuticals Max Drawdown (5Y): 100.00% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 100.00% |
| September 30, 2024 | 100.00% |
| August 31, 2024 | 100.00% |
| July 31, 2024 | 100.00% |
| June 30, 2024 | 100.00% |
| May 31, 2024 | 100.00% |
| April 30, 2024 | 100.00% |
| March 31, 2024 | 100.00% |
| February 29, 2024 | 100.00% |
| January 31, 2024 | 100.00% |
| December 31, 2023 | 100.00% |
| November 30, 2023 | 100.00% |
| October 31, 2023 | 99.99% |
| September 30, 2023 | 99.99% |
| August 31, 2023 | 99.99% |
| July 31, 2023 | 99.99% |
| June 30, 2023 | 99.99% |
| May 31, 2023 | 99.99% |
| April 30, 2023 | 99.98% |
| March 31, 2023 | 99.96% |
| February 28, 2023 | 99.83% |
| January 31, 2023 | 99.82% |
| December 31, 2022 | 99.82% |
| November 30, 2022 | 99.68% |
| October 31, 2022 | 99.68% |
| Date | Value |
|---|---|
| September 30, 2022 | 99.68% |
| August 31, 2022 | 99.68% |
| July 31, 2022 | 99.68% |
| June 30, 2022 | 99.68% |
| May 31, 2022 | 99.68% |
| April 30, 2022 | 99.66% |
| March 31, 2022 | 99.66% |
| February 28, 2022 | 99.66% |
| January 31, 2022 | 99.66% |
| December 31, 2021 | 99.66% |
| November 30, 2021 | 99.66% |
| October 31, 2021 | 99.66% |
| September 30, 2021 | 99.66% |
| August 31, 2021 | 99.66% |
| July 31, 2021 | 99.66% |
| June 30, 2021 | 99.66% |
| May 31, 2021 | 99.66% |
| April 30, 2021 | 99.66% |
| March 31, 2021 | 99.66% |
| February 28, 2021 | 99.66% |
| January 31, 2021 | 99.66% |
| December 31, 2020 | 99.66% |
| November 30, 2020 | 99.66% |
| October 31, 2020 | 99.66% |
| September 30, 2020 | 99.66% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.08%
Minimum
Nov 2019
100.00%
Maximum
Oct 2024
99.75%
Average
99.67%
Median
Max Drawdown (5Y) Benchmarks
| Adaptimmune Therapeutics PLC | 96.57% |
| Verona Pharma PLC | 89.71% |
| NuCana PLC | -- |
| Autolus Therapeutics PLC | -- |
| TC BioPharm (Holdings) PLC | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -108.12 |
| Beta (5Y) | 1.430 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 104.0% |
| Historical Sharpe Ratio (5Y) | -0.8619 |
| Historical Sortino (5Y) | -1.403 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 52.96% |